{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T03:49:25Z","timestamp":1785728965680,"version":"3.56.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T00:00:00Z","timestamp":1738972800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"Netherlands Organisation for Health Research and Development","doi-asserted-by":"publisher","award":["10430062010001"],"award-info":[{"award-number":["10430062010001"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["UKRIDHSC COV19-RECPLAS"],"award-info":[{"award-number":["UKRIDHSC COV19-RECPLAS"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["101015756"],"award-info":[{"award-number":["101015756"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Federal Ministry of Education and Research Bonn Office","doi-asserted-by":"publisher","award":["16LW0108"],"award-info":[{"award-number":["16LW0108"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009033","name":"NHS Blood and Transplant","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009033","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ebiom.2025.105613","type":"journal-article","created":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T14:01:37Z","timestamp":1740664897000},"page":"105613","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19: an international, randomised, open-label trial"],"prefix":"10.1016","volume":"113","author":[{"given":"Simone","family":"Hoffmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Schrezenmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3801-5297","authenticated-orcid":false,"given":"Maxime","family":"Desmarets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Halleck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Durrbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4882-6816","authenticated-orcid":false,"given":"Lynn","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Teresa","family":"Tremmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Seidel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marita","family":"F\u00fchrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friederike","family":"Bachmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Schrezenmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Greiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sixten","family":"K\u00f6rper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrike","family":"Hofmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Vieweg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Jahrsd\u00f6rfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klemens","family":"Budde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"M\u00fcnch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nizar","family":"Joher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Daguindau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beate","family":"Gr\u00fcner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00eblle","family":"Brunotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5106-7369","authenticated-orcid":false,"given":"Charline","family":"Vauchy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erhard","family":"Seifried","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7186-2482","authenticated-orcid":false,"given":"Daniel","family":"Bradshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise J.","family":"Estcourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Toussirot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Rijnders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Tiberghien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1222-6659","authenticated-orcid":false,"given":"Hubert","family":"Schrezenmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2025.105613_bib1","article-title":"Convalescent plasma for people with COVID-19: a living systematic review","volume":"5","author":"Iannizzi","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ebiom.2025.105613_bib2","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMoa2033700","article-title":"Early high-titer plasma therapy to prevent severe Covid-19 in older adults","volume":"384","author":"Libster","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ebiom.2025.105613_bib3","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1056\/NEJMoa2119657","article-title":"Early outpatient treatment for Covid-19 with convalescent plasma","volume":"386","author":"Sullivan","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ebiom.2025.105613_bib4","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S2213-2600(21)00545-2","article-title":"High-titre methylene blue-treated convalescent plasma as an early treatment for outpatients with COVID-19: a randomised, placebo-controlled trial","volume":"10","author":"Alemany","year":"2022","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.ebiom.2025.105613_bib5","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1038\/s41467-022-29911-3","article-title":"Prospective individual patient data meta-analysis of two randomized trials on convalescent plasma for COVID-19 outpatients","volume":"13","author":"Millat-Martinez","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2025.105613_bib6","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.cmi.2022.08.005","article-title":"Outpatient convalescent plasma therapy for high-risk patients with early COVID-19: a randomized placebo-controlled trial","volume":"29","author":"Gharbharan","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ebiom.2025.105613_bib7","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1056\/NEJMoa2103784","article-title":"Early convalescent plasma for high-risk outpatients with Covid-19","volume":"385","author":"Korley","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ebiom.2025.105613_bib8","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1001\/jamaoncol.2021.1799","article-title":"Association of convalescent plasma therapy with survival in patients with hematologic cancers and COVID-19","volume":"7","author":"Thompson","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ebiom.2025.105613_bib9","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/s41375-022-01511-6","article-title":"Convalescent plasma improves overall survival in patients with B-cell lymphoid malignancy and COVID-19: a longitudinal cohort and propensity score analysis","volume":"36","author":"Hueso","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.ebiom.2025.105613_bib10","doi-asserted-by":"crossref","first-page":"436","DOI":"10.3390\/v13030436","article-title":"Early administration of convalescent plasma improves survival in patients with hematological malignancies and COVID-19","volume":"13","author":"Biernat","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.ebiom.2025.105613_bib11","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.00400-24","article-title":"Outpatient treatment with concomitant vaccine-boosted convalescent plasma for patients with immunosuppression and COVID-19","volume":"15","author":"Ripoll","year":"2024","journal-title":"mBio"},{"key":"10.1016\/j.ebiom.2025.105613_bib12","doi-asserted-by":"crossref","first-page":"5951","DOI":"10.1182\/bloodadvances.2022008932","article-title":"Vaccine-boosted convalescent plasma therapy for patients with immunosuppression and COVID-19","volume":"6","author":"Ripoll","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.ebiom.2025.105613_bib13","doi-asserted-by":"crossref","DOI":"10.1172\/JCI155114","article-title":"A\u00a0randomized controlled study of convalescent plasma for individuals hospitalized with COVID-19 pneumonia","volume":"131","author":"Bar","year":"2021","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ebiom.2025.105613_bib14","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1001\/jama.2021.18178","article-title":"Effect of convalescent plasma on organ support-free days in critically ill patients with COVID-19: a randomized clinical trial","volume":"326","author":"Estcourt","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.ebiom.2025.105613_bib15","first-page":"96","article-title":"Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial","volume":"4","author":"Denkinger","year":"2023","journal-title":"Nat Cancer"},{"key":"10.1016\/j.ebiom.2025.105613_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/bmjmed-2022-000427","article-title":"Use of covid-19 convalescent plasma to treat patients admitted to hospital for covid-19 with or without underlying immunodeficiency: open label, randomised clinical trial","volume":"2","author":"Lacombe","year":"2023","journal-title":"BMJ Med"},{"key":"10.1016\/j.ebiom.2025.105613_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-071277","article-title":"Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19 (COVIC-19): protocol for a randomised, open-label trial","volume":"13","author":"Desmarets","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.ebiom.2025.105613_bib18","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/j.immuni.2022.09.006","article-title":"SARS-CoV-2 in immunocompromised individuals","volume":"55","author":"DeWolf","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.ebiom.2025.105613_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abj1031","article-title":"Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patients","volume":"6","author":"Rincon-Arevalo","year":"2021","journal-title":"Sci Immunol"},{"key":"10.1016\/j.ebiom.2025.105613_bib20","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41586-021-03696-9","article-title":"Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection","volume":"595","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2025.105613_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1170759","article-title":"SARS-CoV-2 vaccination of convalescents boosts neutralization capacity against Omicron subvariants BA.1, BA.2 and BA.5 and can be predicted by anti-S antibody concentrations in serological assays","volume":"14","author":"Seidel","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.ebiom.2025.105613_bib22","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I","article-title":"Interval estimation for the difference between independent proportions: comparison of eleven methods","volume":"17","author":"Newcombe","year":"1998","journal-title":"Stat Med"},{"key":"10.1016\/j.ebiom.2025.105613_bib23","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.50647","article-title":"COVID-19 convalescent plasma for the treatment of immunocompromised patients: a systematic review and meta-analysis","volume":"6","author":"Senefeld","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ebiom.2025.105613_bib24","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41579-023-00878-2","article-title":"The evolution of SARS-CoV-2","volume":"21","author":"Markov","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ebiom.2025.105613_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1389345","article-title":"Omicron SARS-CoV-2 infection management and outcomes in patients with hematologic disease and recipients of cell therapy","volume":"14","author":"Pinana","year":"2024","journal-title":"Front Oncol"},{"key":"10.1016\/j.ebiom.2025.105613_bib26","article-title":"Clinical feature of omicron infection in children with inborn errors of immunity in China","volume":"15","author":"Yang","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.ebiom.2025.105613_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.20411\/pai.v10i1.752","article-title":"Escape of SARS-CoV-2 variants KP.1.1, LB.1, and KP3.3 from approved monoclonal antibodies","volume":"10","author":"Planas","year":"2024","journal-title":"Pathog Immun"},{"key":"10.1016\/j.ebiom.2025.105613_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.920210","article-title":"BNT162b2 booster vaccination elicits cross-reactive immunity against SARS-CoV-2 variants B.1.1.529 and B.1.617.2 in convalescents of all ages","volume":"13","author":"Jahrsdorfer","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.ebiom.2025.105613_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2022.10677","article-title":"SARS-CoV2 mRNA vaccine-specific B-, T- and humoral responses in adolescents after kidney transplantation","volume":"35","author":"Sattler","year":"2022","journal-title":"Transpl Int"},{"key":"10.1016\/j.ebiom.2025.105613_bib30","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.157836","article-title":"Temporary antimetabolite treatment hold boosts SARS-CoV-2 vaccination-specific humoral and cellular immunity in kidney transplant recipients","volume":"7","author":"Schrezenmeier","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.ebiom.2025.105613_bib31","first-page":"2565","article-title":"Serological response to three, four and five doses of SARS-CoV-2 vaccine in kidney transplant recipients","volume":"11","author":"Osmanodja","year":"2022","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.ebiom.2025.105613_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104448","article-title":"Modeling explains prolonged SARS-CoV-2 nasal shedding relative to lung shedding in remdesivir-treated rhesus macaques","volume":"25","author":"Goyal","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.ebiom.2025.105613_bib34","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41586-021-03291-y","article-title":"SARS-CoV-2 evolution during treatment of chronic infection","volume":"592","author":"Kemp","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2025.105613_bib35","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1126\/science.abf6950","article-title":"Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape","volume":"371","author":"McCarthy","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.ebiom.2025.105613_bib36","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/s41586-021-03471-w","article-title":"Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma","volume":"593","author":"Cele","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2025.105613_bib37","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1001\/jama.2021.7212","article-title":"Researchers tie severe immunosuppression to chronic COVID-19 and virus variants","volume":"325","author":"Abbasi","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.ebiom.2025.105613_bib38","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1056\/NEJMoa2031893","article-title":"Convalescent plasma antibody levels and the risk of death from Covid-19","volume":"384","author":"Joyner","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ebiom.2025.105613_bib39","doi-asserted-by":"crossref","DOI":"10.1172\/JCI152264","article-title":"Results of the CAPSID randomized trial for high-dose convalescent plasma in patients with severe COVID-19","volume":"131","author":"K\u00f6rper","year":"2021","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ebiom.2025.105613_bib40","doi-asserted-by":"crossref","DOI":"10.1172\/JCI163657","article-title":"One-year follow-up of the CAPSID randomized trial for high-dose convalescent plasma in severe COVID-19 patients","volume":"132","author":"Korper","year":"2022","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ebiom.2025.105613_bib41","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.ajpath.2020.05.014","article-title":"Treatment of coronavirus disease 2019 (COVID-19) patients with convalescent plasma","volume":"190","author":"Salazar","year":"2020","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ebiom.2025.105613_bib42","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2025.105613_bib43","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41577-020-0359-5","article-title":"Dissecting antibody-mediated protection against SARS-CoV-2","volume":"20","author":"Zohar","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ebiom.2025.105613_bib44","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.3390\/v13081594","article-title":"COVID-19 convalescent plasma is more than neutralizing antibodies: a narrative review of potential beneficial and detrimental co-factors","volume":"13","author":"Focosi","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.ebiom.2025.105613_bib45","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/trf.17701","article-title":"Safety of COVID-19 convalescent plasma: a definitive systematic review and meta-analysis of randomized controlled trials","volume":"64","author":"Franchini","year":"2024","journal-title":"Transfusion"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235239642500057X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235239642500057X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T16:18:09Z","timestamp":1762618689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S235239642500057X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":44,"alternative-id":["S235239642500057X"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105613","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19: an international, randomised, open-label trial","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105613","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105613"}}